AVANDIA - 0173-0836-13 - (rosiglitazone maleate)

Alphabetical Index


Drug Information of AVANDIA

Product NDC: 0173-0836
Proprietary Name: AVANDIA
Non Proprietary Name: rosiglitazone maleate
Active Ingredient(s): 8    mg/1 & nbsp;   rosiglitazone maleate
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of AVANDIA

Product NDC: 0173-0836
Labeler Name: GlaxoSmithKline LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021071
Marketing Category: NDA
Start Marketing Date: 20110525

Package Information of AVANDIA

Package NDC: 0173-0836-13
Package Description: 30 TABLET, FILM COATED in 1 BOTTLE (0173-0836-13)

NDC Information of AVANDIA

NDC Code 0173-0836-13
Proprietary Name AVANDIA
Package Description 30 TABLET, FILM COATED in 1 BOTTLE (0173-0836-13)
Product NDC 0173-0836
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name rosiglitazone maleate
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20110525
Marketing Category Name NDA
Labeler Name GlaxoSmithKline LLC
Substance Name ROSIGLITAZONE MALEATE
Strength Number 8
Strength Unit mg/1
Pharmaceutical Classes Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient]

Complete Information of AVANDIA


General Information